Category:
Semaglutide
The dosing being studied for weight loss is 2.4 mg once weekly, which is currently higher than the doses approved in diabetes. What’s more, Semaglutide is being studied in a different population: people with a body mass index (BMI) greater than or equal to 30 kg/m? alone or 27 kg/m? with at least one weight-related comorbidity (diabetes excluded).